The Qbtech Story

The story of Qbtech (Quantitative behaviour technology) began in Gothenburg, Sweden in 2002. By developing proprietary algorithms, precise motion tracking and unique tests of attention allied to an outcome-focused database we created the world’s first FDA cleared and CE marked ADHD Management System, QbTest. 

Our vision is to transform healthcare by providing a complete system of leading objective tests, products and services that empower clinical and financial decision makers to improve outcomes and support patients to better understand their symptoms and treatment.

Qbtech is currently serving 14 countries and has offices in Sweden, the United Kingdom, the Unites States and Germany. Since we believe that improved outcomes are key, QbTest, our onsite system designed for larger specialised clinics, and QbCheck, our online system designed for primary care and ADHD generalists, always include training, development and support to maximise the utility as well as continuous upgrades to access latest research and technical developments.

Both QbTest and QbCheck are FDA-cleared and CE-marked to aid in the assessment and treatment evaluation of ADHD.

What We Do

As a market leader in objective ADHD Management, we are working to provide innovative, effective and well-documented products and services designed to assist in all aspects of assessment and monitoring of ADHD. Our aim is to:

  • Improve quality in the identification and referral of patients
  • Improve the ability of clinicians to correctly diagnose ADHD and improve differential diagnosis
  • Improve quality when clinicians evaluate treatment options
  • Improve the ability of qualified professionals to support patients over time
  • Improve the ability for clinics and clinicians to effectively allocate resources 

Qbtech is working with leading academic and clinical researchers, technology companies and patient associations to achieve our vision of transforming healthcare. More than 25 studies are ongoing at any time – please contact us if you have a suggestion or idea on how to transform ADHD management.   

Our Management Team

Carl Reuterskiöld

Carl Reuterskiöld

CEO

Carl joined Qbtech in 2009. His previous experience includes various commercial and leadership roles within Pfizer as well as strategic and analytical roles within the Boston Consulting Group. M.Sc.

Hans Boström

Medical Director

Hans has a M.Sc. in Pharmacy and PhD in Biochemistry. He joined Qbtech in 2010 and has an extensive experience within Clinical Research and Regulatory Affairs from different positions in the Life Science industry.

Tony Doyle

Commercial Director

Before joining Qbtech in 2010, Tony worked at Pfizer where he gained extensive experience leading strategic and commercial groups in the UK and across Europe. B.Sc.

Gunnar Haawind

CFO

Gunnar holds a M.Sc. in Business Administration and Economics. He joined Qbtech in 2012 and has worked as a consultant at PwC with a portfolio of international clients from mainly Pharma and the Retail industry

Come Join Us

We are always looking for great people to hire!

CAREERS